Back to Agenda
Session 1 continued: LACK OF ADHERENCE AND THE CHOICE OF THE RIGHT ESTIMAND IN CLINICAL TRIALS
Session Chair(s)
Norbert Benda, PHD
Head of Biostatistics and Special Pharmacokinetics, Federal Institute For Drugs and Medical Devices (BfArM), Germany
William Malbecq, DRSC
Head of Biostatistics Europe, MSD, Belgium
Speaker(s)
Ann-Kristin Leuchs
Statistician, Bfarm, Germany
Applicability and appropriateness of de-facto and de-jure estimands in drug approval
David Brown, MSC
Head of Statistics Team, Healthcare, Quality and Access, Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom
Estimands and the Handling of Missing Data: Regulatory Evolution
Have an account?
